H.C. Wainwright raises Alto Neuroscience target price to $60 from $55
ANRO•H.C. Wainwright raised its target price for Alto Neuroscience to $60 from $55.
Related News
Adia Med sells 7% stake in Adia Labs to CEO for $350,000
ADIA•
AI risks rise faster than business value, Gartner says
IT•
Fresenius Medical Care managing body member Martin Fischer acquires €50,440.02 in shares
FMS•
NCR Atleos partners with First Citizens Bank for surcharge-free ATM access at over 2,000 Target stores
NATL•